ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1511	National Cancer Institute	Html	en	Small Cell Lung Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of small cell lung cancer.	clinical trial 0.236127 treatment 0.276669 patients 0.200061 Lung Cancer Prevention 0.201183 cancer cells 0.289303 body 0.206914 Lung Cancer Treatment 0.223408	PDQ cancer information 0.202281 cell lung cancer 0.911961 small cell lung 0.946074 radiation therapy 0.266516 National Cancer Institute 0.212636 clinical trials 0.458637 information 0.20384	CLICK HERE
1574	National Cancer Institute	Html	en	Parathyroid Cancer Treatment (PDQ®)–Patient Version	The parathyroid glands are four pea-sized organs found in the neck near the thyroid gland. Find out about risk and genetic factors, symptoms, tests to diagnose, prognosis, staging, and treatment for parathyroid cancer.	entire parathyroid gland 0.322718 body 0.312231 Parathyroid hormone test 0.326008 PDQ cancer information 0.344395 clinical trial search 0.297288 parathyroid cancer spreads 0.351955 cancer information summary 0.316321 clinical trial 0.381391 parathyroid hormone 0.446163 patients 0.279411 treatment clinical trial 0.267117 NCI PDQ cancer 0.284168 parathyroid cancer 0.907418 parathyroid gland 0.458873 lymph nodes 0.287148 supportive care 0.306655 radiation therapy 0.415255 Recurrent parathyroid cancer 0.380003 Treatment Editorial Board 0.27063 metastatic parathyroid cancer 0.402384 general cancer information 0.273517 treatment 0.412907 Parathyroid Cancer Home 0.340383 new cancer treatments 0.272069	benign parathyroid adenoma 0.327035 NCI-supported cancer 0.273639 cancer cells 0.359072 standard treatment 0.270825 parathyroid cancer look 0.361006 parathyroid adenoma 0.339034 Cancer Information Service 0.274336 treatment clinical trials 0.292746 National Cancer Institute 0.358229 Parathyroid Cancer Treatment 0.357344 new treatment 0.296569 calcium 0.286368 clinical trials 0.583365 radioactive substance 0.27332 Cancer Care page 0.26586 overactive parathyroid gland 0.335807 Blood. The cancer 0.269699 blood 0.359167 cancer research process 0.266446 cancer clinical trials 0.322533 tumor 0.275377 cancer information summaries 0.272885 comprehensive cancer information 0.272952 parathyroid cancer signs 0.373584	CLICK HERE
1676	National Cancer Institute	Html	en	Langerhans Cell Histiocytosis Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood Langerhans Cell Histiocytosis.	LCH lesions. 0.60623 skin lch 0.608961 high-risk LCH cases 0.650922 LCH lesions 0.663265 single-system LCH 0.624334 children 0.471295 pediatric LCH 0.607323 LCH cells 0.745404 myeloid dendritic cell 0.510622 diabetes insipidus 0.672442 Langerhans cell histiocytosis 0.581215 patients 0.683188 LCH cases 0.700352 active LCH 0.597856 multisystem involvement 0.464638 multisystem LCH 0.682353 BRAF V600E mutation 0.597618 LCH 0.901252 skin-only lch 0.612216 low-risk multisystem patients 0.491439 lung LCH cases 0.608969 high-risk multisystem disease 0.475673 myeloid dendritic cells 0.467176 aggressive LCH 0.578735 high-risk patients 0.467752	multisystem low-risk LCH 0.641412 involvement 0.465609 adult patients 0.4596 adult lung LCH 0.600979 multiorgan LCH resistant 0.594436 central diabetes insipidus 0.487545 initial LCH diagnosis 0.610781 multisystem disease 0.512583 Peribiliary LCH cells 0.620201 disease 0.533739 LCH biopsy specimens 0.639356 hepatic LCH present 0.615144 pulmonary LCH cases 0.613089 LCH cells results 0.654905 LCH patients 0.65009 LCH results 0.628645 childhood LCH 0.575582 bone marrow 0.506353 diabetes insipidus patients 0.500508 diabetes insipidus onset 0.465094 diabetes insipidus development 0.465011 term LCH cells 0.651456 pulmonary lch 0.712872 low-risk multisystem disease 0.474286	CLICK HERE
1701	National Cancer Institute	Html	en	Pathology Reports	A fact sheet describing the information found in a pathology report, the document that contains results of the examination of tissue removed during biopsy or surgery.	NCI-designated cancer centers 0.497751 technical medical language 0.492686 pathology report 0.906587 certain noncancerous conditions 0.486594 pathology results 0.507902 tissue 0.71912 Pathology reports 0.571018 cancer cells 0.487918 malignant cells 0.475383 Cancer Information Service 0.505692 microscope 0.502866 ) sections. 0.523472 different cancer types 0.498063 frozen section 0.50145 naked eye 0.506619 permanent) sections. 0.503784 clinical trials 0.546491 flow cytometry 0.487161 tumor cells 0.49749 normal cells 0.47705 particular DNA sequence 0.477991 entire tumor 0.507705 tumor markers 0.496268	tissue culture 0.501671 tissue sample 0.575447 chronic myelogenous leukemia 0.479887 diagnosis 0.476227 normal tissue 0.5122 pathology laboratory 0.521862 tissue samples 0.511673 frozen sections 0.490304 clinical trials page 0.487126 particular DNA sequences 0.478454 Polymerase chain reaction 0.483064 Western blot hybridization 0.484206 cells 0.582619 tissue firm 0.512918 biopsy date 0.47785 live cells 0.477142 gross description 0.504759 biopsy 0.507407 particularly genetic alterations 0.48591 information 0.537969 cancer 0.518713 pathologist 0.518021 pathology specimens 0.507289	CLICK HERE
1778	National Cancer Institute	Html	es	Delirium (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del delirium como una complicación del cáncer o su tratamiento. Se discuten los abordajes de los cuidados médicos de apoyo, así como farmacológicos para el manejo del delirium.	delirium rating 0.635037 Cancer Res Clin 0.330668 Breitbart W 0.391378 recognizing delirium 0.408363 Misdiagnosing delirium 0.408657 Sin embargo 0.38098 delirium among elderly 0.415971 Fainsinger RL 0.329645 Lipowski ZJ 0.334677 Gagnon B 0.354723 Predicting delirium 0.41556 risk factors 0.327409 Delirium Assessment Scale 0.517982 Delirium risk 0.412345 Delirium presenting with 0.419293 patients with delirium 0.445355 Natl Cancer Inst 0.328774 antipsicóticos típicos 0.342502 McCallion J 0.33665 Lawlor PG 0.511955 término delirium 0.437321 Neuropsychiatry Clin Neurosci 0.328992 Mancini IL 0.351836 hospitalized patients with 0.376004 específica cuáles pacientes 0.32777	Palliat Care 0.338189 patients with 0.960984 Pain Symptom Manage 0.86069 prevent delirium 0.429024 Miller L 0.327272 American Psychiatric Association 0.3525 bedside confusion scale 0.336758 Care Cancer 0.332558 palliative care 0.358676 hospitalized elderly 0.35987 Memorial Delirium Assessment 0.513933 Delirium after 0.413891 Intern Med 0.666809 delirium rating scale-revised-98 0.51332 confusion assessment method 0.339276 Clin Oncol 0.334335 Arch Intern Med 0.574627 Bruera E 0.37373 with adjuvant 0.332147 elderly patient 0.402747 terminal delirium 0.422735 antipsicóticos atípicos 0.439946 prospective study 0.581043 Inouye SK 0.47182	CLICK HERE
1905	National Cancer Institute	Html	es	Tratamiento del cáncer de hígado infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de hígado infantil.	grupo iii 0.507215 siguientes procedimientos 0.435845 grupo posttext 0.428004 efectos secundarios meses 0.436827 cuáles secciones 0.430744 pequeña cantidad 0.417301 grupos pretext 0.622136 grupo pretext 0.494022 rayos x 0.426417 niño ayuda 0.426517 grupo ii 0.508034 cuerpo usa 0.472879 ondas sonoras 0.42867 efectos tardíos 0.57237 PDQ Efectos tardíos 0.457898 National Cancer Institute 0.41066 IRMN).Ampliar Imágenes 0.423392	microesferas minúsculas 0.417674 Instituto Nacional 0.442931 PDQ Tratamiento 0.80031 determinados cambios 0.489668 características histológicas 0.903803 nuevos tipos 0.420467 grupo iv 0.455083 distintos tipos 0.457348 Physician Data Query 0.443332 Estados Unidos 0.431258 siguientes situaciones 0.427998 abdomen.ampliar exploración 0.426559 siguientes enlaces 0.410964 altas concentraciones 0.429265 sanguíneos principales.ampliar ecografía 0.456159 siguientes trastornos 0.423684	CLICK HERE
3459	National Cancer Institute	Html	es	Coenzima Q10 (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la conzima Q10 como tratamiento para las personas con cáncer.	Centro Nacional 0.333125 Vitamina Q10 0.341732 New Hampshire Avenue 0.323053 Drug Administration 0.314317 leucemia linfoblástica aguda 0.341078 NCI Best Case 0.342133 vía oral 0.324149 mejores pruebas 0.318969 datos bibliográficos pubmed 0.324983 siguientes preguntas 0.314202 mayores cantidades 0.322901 Premio Nobel 0.323381 siguientes riesgos 0.318032 máximo nivel 0.322444 seguro médico 0.313926 Instituto Nacional 0.428917 vitamina e 0.322593 conzima q10 0.331342 Salud Complementaria 0.35167	Visuals Online 0.317138 complementarias revisa 0.324022 daños causados​por 0.322061 Physician Data Query 0.399292 coenzima q10 0.631002 Estados Unidos 0.532938 cáncer doxorrubicina 0.420236 antraciclina doxorrubicina 0.326213 libre uso 0.31803 página manejo 0.315983 ¿El tratamiento 0.336183 ¿Los beneficios 0.314951 CoQ10 ayuda 0.788819 cuerpo elabora 0.394571 coenzima ayuda 0.33485 Series Program 0.314402 medicina complementaria 0.970585 siguientes deficiencias 0.324091	CLICK HERE
3581	National Cancer Institute	Html	en	Cancer Screening and Early Detection Research	Information about cancer screening and early detection research, including a summary of NCI programs dedicated to advancing screening and early detection.	new screening test 0.540118 cancer deaths 0.410053 NCI family studies 0.383067 lung cancer 0.420741 Breast Cancer Surveillance 0.38723 regular screening 0.445893 colorectal cancer screening 0.603772 early detection 0.939503 certain cancers 0.363738 nonhereditary cancers 0.350447 cancer diagnosis 0.409297 Early Detection Research 0.39067 Colorectal Cancer Outreach 0.419418 invasive diagnostic tests 0.349791 cervical cancer 0.470854 Reduce Cancer Health 0.403575 follow-up screening 0.454414 population groups 0.405687 cancers 0.545666 effective screening tests 0.700094 cancer screening 0.952427 esophageal cancer 0.349174 cancer prevention 0.403966 cancer screening practices 0.592194 United States 0.470337	screening tests 0.828502 early detection tests 0.394525 Cancer Treatment 0.361701 cancer cells 0.354406 new screening tests 0.532154 successful screening approach 0.50247 annual screening 0.507755 screening clinical trials 0.513432 National Lung Screening 0.514111 breast cancer screening 0.628104 potentially lethal cancers 0.414445 advanced cancer 0.354994 Research Optimizing Screening 0.517143 screen-detected cancers 0.368122 cancer screening tests 0.606127 CT-based screening 0.448353 hereditary cancers 0.34998 lung cancer risk 0.409654 false-positive screening tests 0.535547 Screening Initiative 0.447841 cancer mortality 0.418544 screening methods 0.487692 Cancer Screening Trial 0.590657 life-threatening cancers 0.360993	CLICK HERE
3856	National Cancer Institute	Html	en	Christal Sohl, Ph.D.	The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer.	personal time 0.583145 polymerase enzymes 0.576932 isocitrate dehydrogenase 0.57565 environmental pollutants 0.576985 Fred Guengerich 0.587519 cell growth 0.572096 K99/R00 grant application 0.63899 job applications 0.56948 generous people 0.568794 enzyme structure 0.620541 mutated conditions 0.575037 cancer-promoting metabolite 0.574359 Diego State University 0.633881 graduate school 0.57248 single point mutation 0.637959 research career 0.583765 strong mentoring relationships 0.632479 biological substrate 0.582981 daunting prospect 0.569185 enzyme functions 0.618027 Dr. Guengerich 0.599167 tumor-suppressing effects 0.571078 brand-new assistant professor 0.63038 clinically relevant problem 0.636226 research goal 0.576225	SDSU students 0.573824 postdoc Dr 0.580928 kinases—cellular signaling proteins 0.631824 Vanderbilt University 0.576153 cancer drugs 0.568875 R01 grant 0.59259 human disease 0.573514 K99/R00 grant 0.703102 George Richter-Addo 0.576773 undergraduate biochemistry course 0.648526 Yale University 0.573003 enzyme kinetics—the study 0.706771 earlier career stages 0.620329 enzymatic reaction 0.574931 inaccurate DNA replication 0.627233 assistant professor 0.762524 Karen Anderson 0.570977 K99/R00 transition grant 0.643727 Dr. Sohl 0.961111 hard work 0.580209 enzyme kinetics—and 0.636377 single step 0.57426 DNA strands 0.56849 Christal Sohl 0.703616	CLICK HERE
15671	National Cancer Institute	Html	en	National Cancer Institute Overview and Mission	Learn about the National Cancer Institute and what we do, our impact, and our future plans.	NCI Budget Fact 0.497121 federally funded research 0.465442 research education 0.373076 cancer deaths 0.368559 research efforts 0.378749 clinical trial sites 0.42553 improved cancer treatments 0.481082 new cancer cases 0.455562 private-sector life sciences 0.407381 research career development 0.478109 clinical trials 0.413733 publicly available cancer 0.474225 National Institutes 0.330098 cancer patients 0.381628 research laboratories 0.378804 comprehensive training programs 0.420146 NCI 0.551669 clinical research 0.391338 cancer survivors 0.364801 training opportunities 0.416201 intramural training programs 0.437578 National Cancer Program 0.503712 career development opportunities 0.414542 Funds training 0.333548 advanced technology development 0.398899	Maintains long-term storage 0.390918 cancer prevention 0.393108 United States 0.478805 training grants 0.329153 cancer research 0.942525 private philanthropic organizations 0.403666 scientific knowledge 0.423431 cancer research disciplines 0.531444 various research programs 0.452562 National Cancer Institute 0.528313 NCI laboratories 0.431835 cancer researchers 0.38535 research institutions 0.37224 Supports intramural research 0.523044 innovative laboratory research 0.451762 Frederick National Laboratory 0.407026 cancer detection 0.370327 NCI’s expenditures 0.416543 career development 0.479695 cancer care delivery 0.459112 biomedical research 0.373736 cancer research enterprise 0.566317 NCI’s laboratories 0.427372 NCI-Designated Cancer Centers 0.493446	CLICK HERE